Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort.

H Corominas, I Castellví, V Pomar, R Antonijoan, I Mur, L Matas, I Gich, N de Benito, A Laiz, D Castillo, L Villamarin, D Filella, AM Millán, P Domingo

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)
Original languageUndefined/Unknown
JournalClinical immunology (Orlando, Fla.)
Publication statusPublished - Nov 2020

Cite this